Espansione Group

14/09/2025

11/09/2025

🔬 1 Day to Go | Join Us at ESCRS 2025
📍 Hall C · Booth C1.180

Tomorrow at ESCRS, we launch the InSight Speech Series—a daily program of live scientific talks hosted at our booth, featuring leading voices in ocular innovation.

🎤 Join Prof. Giannaccare, Dr. Daya, Prof. Wolffsohn, Dr. Trave-Huarte, Prof. Piñero, Dr. Stonecipher, Dr. Timofte, Dr. Valdez-Garcia and others as they share clinical insights on:
✅ TFOS DEWS III Report & Dry Eye
✅ Surgical outcomes & post-op DED
✅ Ocular microbiome & LLLT
✅ Demodex blepharitis
✅ PBM for AMD: multicentric data
✅ Screening innovation in ocular surface care

Whether you’re focused on the ocular surface or retinal therapy, this is where science meets practice—live.

👉 View the full agenda & add to your calendar:
https://espansionegroup.it/espansione-group-at-escrs-2025/

Let’s move science forward.
See you tomorrow at Booth C1.180.

04/09/2025

Just one day to go—discover one of the standout session of the Euretina 2025 Congress.

You're invited to join our expert-led symposium:

Light Modulation™ LLLT (PBM): A New Frontier in Retinal Care & Beyond
🗓 September 5th | 🕔 17:45–18:45
📍 Amphithéâtre Havane, Level 3, Le Palais des Congrès, Paris

🎓 Speakers: Prof. Giannaccare | Prof. Demirel | Prof. Borrelli | Dr. Iovino | Dr. Viggiano
🎤 Moderators: Dr. Bacherini | Prof. Zur | Prof. Mastropasqua

In this one-hour session, we’ll explore the science, mechanisms, and clinical evidence behind PBM as a non-invasive therapeutic strategy for Dry Age-related Macular Degeneration and beyond.

Also happening at Euretina 2025:
- Prof. Borrelli (Italy) ePoster: 12-Month Efficacy of Photobiomodulation Treatment in Dry Age-Related Macular Degeneration Using the eye-light® Device” | ePoster & Video Terminals on Level 3

🔗 Explore the full program and join us in Paris to discover the future of light-based retinal therapy.

📌 Visit us throughout the congress at EssilorLuxottica Booth 3.A25

28/08/2025

🔬 ESCRS 2025 | InSight Speech Series at Booth C1.180

This ESCRS, experience the power of real-world clinical insight—right from the show floor.
Every day, leading KOLs will present breakthrough insights on photobiomodulation—from TFOS DEWS III Report and pre-/post-surgery DED, to ocular microbiome, Demodex and retinal care.

Meet the experts driving innovation in ocular surface management and retinal care: Prof. G. Giannaccare, Dr. S. Daya, Prof. J. Wolffsohn, Dr. S. Travé-Huarte, Prof. D. P. Piñero, Dr. K. Stonecipher, Dr. M. Timofte, Dr. A. Losada Rodriguez, Dr. J. E. Valdez-Garcia and others.

This is not just another booth—it’s a daily space for scientific exchange.
📍 Booth C1.180 | Hall C

Add to your calendar:
https://espansionegroup.it/espansione-group-at-escrs-2025/

31/07/2025

🔬 Where Light Meets Science

Join us at ESCRS 2025—Hall C, Booth C1.180—your destination for in-depth exchange with world-leading experts.

Every day, our InSight Speech Series brings thought leaders to the booth to share cutting-edge research and clinical insights on our technologies.

Dive into the future of anterior segment care and photobiomodulation with discussions on Dry Eye Disease and postoperative DED management, the recent TFOS DEWS III Report, Demodex Blepharitis and more.

Real science. Real results. Straight from the experts.

We look forward to welcoming you in Copenhagen.

Discover More Now!
👉https://espansionegroup.it/espansione-group-at-escrs-2025/

29/07/2025

🔬 Innovation meets Science at Euretina 2025

From September 4th to 7th, join us at the EssilorLuxottica Booth (3.A25) to discover how Light Modulation™ LLLT (PBM) is redefining retinal care.

Photobiomodulation is at the forefront of early, non-invasive management of degenerative retinal conditions such as Age-related Macular Degeneration (AMD).

If you’re keen to dive deeper, don’t miss our symposium on the expanding role of PBM in retinal therapeutics and join the conversation with top-tier KOLs (Prof. Enrico Borrelli | Dr. Claudio Iovino | Dr. Pasquale Viggiano | Prof. Sibel Demirel | Prof. Giuseppe Giannaccare) and stellar moderators (Dr. Daniela Bacherini, Dr. Dinah Zur, Dr. Rodolfo Mastropasqua).

📅 September 5 | 🕔 17:45–18:45
📍 Amphithéâtre Havane, Le Palais des Congrès, Paris

Let’s connect in Paris to shape the future of light-based ophthalmic care.

23/07/2025

As July sheds light on Dry Eye Awareness Month, we take a moment to recognize World Sjögren’s Day, and the unique challenges faced by patients suffering from this autoimmune disease.

Often, these individuals experience severe symptoms that don’t respond to traditional treatments.

📑 That’s where science steps in.
In a 2021 study, Di Marino et al. demonstrated that the combination of OPE™ IPL and LM™ LLLT, delivered via our eye-light® platform, can significantly improve the evaporative component of DED in patients with ’s Syndrome.

We’re proud to support the clinical community in rethinking how we manage complex ocular surface diseases—through , , therapeutics.

22/07/2025

As we advance in Awareness Month, our momentum continues.
A few weeks after our recognition by (Tear Film & Ocular Surface Society) within the DEWS III Report, an acknowledgment confirming the potential of light therapy within the dry eye disease (DED) management challenge has been published by Tan et al. on Current Opinion in Ophthalmology.

The study dives deeper on the potential of as a rising standard in ophthalmology.

🧬 Espansione Group’s eye-light® platform and LM™ LLLT (PBM) technology are featured across a wide array of trials, covering both the front and the back of the eye, reinforcing our leading role in light-based, non-invasive therapeutics in eye care.

There’s still a lot to be done, but everything counts towards giving everyone access to non-invasive, painless management tools of ophthalmic diseases.

Thanks to the authors for this piece of work and paving the way for what will be next in this field. Chris L., Raymond P. Najjar, PhD, Giuseppe Giannaccare

🔗 Access the publication: https://pubmed.ncbi.nlm.nih.gov/40471752/

15/07/2025

As we raise awareness on Awareness Month, we’re proud to share new clinical evidence confirming the efficacy of our Light Modulation™ technology.

📄 In a recent randomized paired-eye trial published by Jeremy Chiang et al., our eye-light® platform was tested by employing both IPL+LLLT and LLLT-only therapeutic approaches, showing:
🔹 Improved tear film stability and reduction of symptom severity in both groups
🔹 Similar meibum expressibility in both instances
🔹 Sustained benefits up to 3 months post-treatment in the LLLT-only group

The study also shed light on LLLT’s ability to deliver results when employed alone, especially in those instances where IPL is contraindicated.

🔗 Dive deeper and review the full-length study: https://www.contactlensjournal.com/article/S1367-0484(25)00090-6/fulltext

This piece of literature outcomes reinforces what clinicians see every day—and echo the recent Tear Film & Ocular Surface Society (TFOS) DEWS III Report findings, where our light-based technological platform has been recognized as safe and effective option for managing and .

10/07/2025

July is Awareness Month.

It’s time to shine a light on this condition affecting millions worldwide, yet one that to this day goes too often undiagnosed and underserved.

We believe research is the first step towards better care for all.

Today we celebrate all scholars and clinicians at the forefront of ocular surface disease for the time and energy they put into studying this field, diagnosis to treatment.

08/07/2025

🔬 The IV International Dry Eye Congress has come to a close in Lamezia Terme — and once again, it proved to be a key moment for the Dry Eye community.

We’re proud to have been part of this forward-looking event, where science and clinical expertise come together to shape the future of ocular surface care.

A heartfelt thank you to Giovanni Roberto Tedesco and Luca Vigo MD for the kind invitation and for hosting a congress of the highest scientific standard.

One key message emerged clearly: the future of management is already here — and Light Modulation™ LLLT-PBM technology is playing a pivotal role.
With its non-invasive, consistent, and clinically effective results, it is fast becoming an essential tool for eye care professionals aiming to restore stability and support health.

👏 A special thank you to the experts who shared their real-world insights on stage: Giuseppe Giannaccare, David P. Piñero, Dr Sònia Travé-Huarte, Carmen Sannace and Davide Borroni — your contribution drives the conversation forward.

We leave Calabria inspired and committed to continuing the mission: delivering consistent, innovative care to every patient — every day.

17/06/2025

What a weekend in Heidelberg for the 2025 International SPECTRALIS Symposium (ISS)!

Scientific discourse of the highest tier, paired with plenty of occasions to connect and engage in inspiring conversations with specialists from all over the world, made these days feel truly instrumental to our mission of shaping the future of .

A truly unforgettable moment?
The keynote by Warren Hoburg, NASA - National Aeronautics and Space Administration Astronaut and mission pilot, who shared his incredible experience working in zero gravity aboard the International Space Station. A powerful reminder of the value of precision, vision, and innovation—in space and alike.

Thank you to our colleagues over for bringing us along at such an outstanding event, and to every scholar who shared their vision with community.